Conatus Pharmaceuticals Inc. (CNAT)

[Theo]

One must assume CNAT is feeling pretty good about their current position and future:

“Bill has raised over $1 billion in public and private equity, debt and partnership financings. As a member of multiple public and private company boards of directors and executive management teams responsible for corporate leadership and growth strategy, his proven experience with business operations, strategic planning, mergers and acquisitions, corporate collaborations and commercialization should serve us well as we advance with the development of our lead product candidate, emricasan.”